← Lobby register
Disclosed budget
€50,000 — €99,999
Meetings 12mo
6
Policy files
6
Accredited passes
0
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 12 Feb 2026 | Olivér Várhelyi Commissioner | EU biotech policy | — |
| 12 Feb 2026 | Karolina Tomaszewska-Boillot Cabinet member | EU biotech policy | — |
| 12 Feb 2026 | Laszlo Andrejko Cabinet member | EU biotech policy | — |
| 12 Feb 2026 | Olivér Várhelyi Commissioner | EU biotech policy | SRC |
| 12 Feb 2026 | Laszlo Andrejko Cabinet member | EU biotech policy | SRC |
| 12 Feb 2026 | Karolina Tomaszewska-Boillot Cabinet member | EU biotech policy | SRC |
Mission & Goals
We are an independent wealth manager specialising in private banking, investment management, and investment banking. With a history spanning nearly three centuries, we are committed to preserving and building the wealth of our clients and society in a sustainable manner. Van Lanschot Kempen shares are listed on Euronext Amsterdam.
EU Legislative Interests
biotech act, capital markets union, life sciences strategy
Interests Represented
Promotes their own interests or the collective interests of their members
Connected Legislation